These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2718604)

  • 21. Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.
    Hägglund S; Hu KF; Larsen LE; Hakhverdyan M; Valarcher JF; Taylor G; Morein B; Belák S; Alenius S
    Vaccine; 2004 Dec; 23(5):646-55. PubMed ID: 15542185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
    Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
    Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of bovine respiratory syncytial virus infection and clinical disease by vaccination.
    Verhoeff J; van Nieuwstadt AP
    Vet Rec; 1984 Nov; 115(19):488-92. PubMed ID: 6097014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
    Hu KF; Regner M; Siegrist CA; Lambert P; Chen M; Bengtsson KL; Morein B
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):269-76. PubMed ID: 15681158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.
    Boxus M; Tignon M; Roels S; Toussaint JF; Walravens K; Benoit MA; Coppe P; Letesson JJ; Letellier C; Kerkhofs P
    J Virol; 2007 Jul; 81(13):6879-89. PubMed ID: 17459933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of immunostimulating complexes (ISCOMs) of Japanese encephalitis virus.
    Yeolekar LR; Banerjee K
    Vaccine; 1996 Nov; 14(16):1553-9. PubMed ID: 9014299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response of calves to immunoaffinity-purified bovine respiratory syncytial virus VP70 after vaccination and challenge exposure.
    Nelson LD; Kelling CL; Anderson GA
    Am J Vet Res; 1992 Aug; 53(8):1315-21. PubMed ID: 1510306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
    Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
    Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12.
    Hancock GE; Smith JD; Heers KM
    Viral Immunol; 2000; 13(1):57-72. PubMed ID: 10733169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quil A and ISCOMs as adjuvants for midgut membrane antigens of Boophilus microplus.
    Jackson LA; Opdebeeck JP
    Appl Parasitol; 1994 Jun; 35(2):87-98. PubMed ID: 8087157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to the fusion protein of bovine respiratory syncytial virus.
    Mulkey KM; Anderson GA
    J Clin Microbiol; 1991 Sep; 29(9):2038-40. PubMed ID: 1723078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques.
    Patton K; Aslam S; Shambaugh C; Lin R; Heeke D; Frantz C; Zuo F; Esser MT; Paliard X; Lambert SL
    Vaccine; 2015 Aug; 33(36):4472-8. PubMed ID: 26206269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture.
    Shao HY; Hsu HS; Yu SL; Wu SR; Hu KC; Chang CK; Liu CC; Chow YH
    Antiviral Res; 2016 Jun; 130():27-35. PubMed ID: 27001351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.
    Hancock GE; Hahn DJ; Speelman DJ; Hildreth SW; Pillai S; McQueen K
    Vaccine; 1994; 12(3):267-74. PubMed ID: 8165859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.